Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Free Cash Flow (2019 - 2026)

Biodesix filings provide 8 years of Free Cash Flow readings, the most recent being -$10.2 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow fell 18.13% to -$10.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$25.1 million, a 44.23% increase, with the full-year FY2025 number at -$23.5 million, up 54.64% from a year prior.
  • Free Cash Flow hit -$10.2 million in Q1 2026 for Biodesix, down from $692000.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $692000.0 in Q4 2025 to a low of -$20.5 million in Q2 2024.
  • Median Free Cash Flow over the past 5 years was -$10.2 million (2026), compared with a mean of -$10.6 million.
  • Biggest five-year swings in Free Cash Flow: plummeted 1326.58% in 2022 and later skyrocketed 114.02% in 2025.
  • Biodesix's Free Cash Flow stood at -$13.9 million in 2022, then fell by 10.01% to -$15.3 million in 2023, then skyrocketed by 67.68% to -$4.9 million in 2024, then skyrocketed by 114.02% to $692000.0 in 2025, then plummeted by 1581.07% to -$10.2 million in 2026.
  • The last three reported values for Free Cash Flow were -$10.2 million (Q1 2026), $692000.0 (Q4 2025), and -$8.9 million (Q3 2025) per Business Quant data.